Nephros (NEPH) Treasury Shares (2017 - 2023)

Nephros' Treasury Shares history runs 6 years deep, the most recent figure standing at $42167.0 for Q4 2023.

• On a quarterly basis, Treasury Shares rose 62.68% year-over-year to $42167.0 in Q4 2023; TTM through Dec 2023 was $42167.0, a 62.68% increase from a year earlier, with the FY2023 full-year figure at $42167.0, up 62.68% from the prior year.
• Treasury Shares advanced to $42167.0 in Q4 2023 per NEPH's latest filing, from $25920.0 in the prior quarter.
• Across five years, Treasury Shares topped out at $55.1 million in Q4 2019 and bottomed at $25920.0 in Q4 2022.
• The 4-year median for Treasury Shares is $50949.5 (2021), against an average of $13.8 million.
• Across the five-year window, Treasury Shares jumped 110365.02% in 2019 and slumped 56.61% in 2022, its largest moves.
• Year by year, Treasury Shares stood at $55.1 million in 2019, then plunged by 99.89% to $59732.0 in 2021, then slumped by 56.61% to $25920.0 in 2022, then soared by 62.68% to $42167.0 in 2023.
• Per Business Quant, the three latest NEPH Treasury Shares figures stand at $42167.0 (Q4 2023), $25920.0 (Q4 2022), and $59732.0 (Q4 2021).